학술논문

Impacts of an Opioid Safety Initiative on US Veterans Undergoing Cancer Treatment
Document Type
article
Source
Journal of the National Cancer Institute. 114(5)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Cancer
Substance Misuse
Pain Research
Prescription Drug Abuse
Chronic Pain
Clinical Trials and Supportive Activities
Clinical Research
Analgesics
Opioid
Humans
Male
Neoplasms
Opioid-Related Disorders
Pain
Pain Management
Practice Patterns
Physicians'
Veterans
Oncology & Carcinogenesis
Oncology and carcinogenesis
Language
Abstract
BackgroundThere is limited research on how the opioid epidemic and consequent risk reduction policies have affected pain management among cancer patients. The purpose of this study was to analyze how the Opioid Safety Initiative (OSI) implemented at the Veterans Health Administration affected opioid prescribing patterns and opioid-related toxicity.MethodsWe performed an interrupted time series analysis of 42 064 opioid-naïve patients treated at the Veterans Health Administration for prostate, lung, breast, and colorectal cancer from 2011 to 2016. Segmented regression was used to evaluate the impact of the OSI on the incidence of any new opioid prescriptions, high-risk prescriptions, persistent use, and pain-related emergency department (ED) visits. We compared the cumulative incidence of adverse opioid events including an opioid-related admission or diagnosis of misuse before and after the OSI. All statistical tests were 2-sided.ResultsThe incidence of new opioid prescriptions was 26.7% (95% confidence interval [CI] = 25.0% to 28.4%) in 2011 and increased to 50.6% (95% CI = 48.3% to 53.0%) by 2013 before OSI implementation (monthly rate of change: +3.3%, 95% CI = 1.3% to 4.2%, P